PF-Atlas › Clinical Trials › NCT01254409
A Phase 1b Study of IV PRM151 in Patients With Idiopathic Pulmonary Fibrosis
PRM-151 · Phase 1
Registry ID
NCT01254409
Phase
Phase 1
Status
Completed
Drug / intervention
PRM-151
Sponsor
Hoffmann-La Roche
Start
2011-03-29
About this trial
PRM-151 is evaluated in NCT01254409, a Phase 1 idiopathic pulmonary fibrosis study sponsored by Hoffmann-La Roche. Current status: Completed.
Explore related
Related trials
Medical disclaimer. This page summarizes public trial data for NCT01254409 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.